SEC Form 4 · accession 0001209191-18-058823
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
H Stewart Parker
Director
Period of report
Nov 14, 2018
Accepted (ET)
Nov 15, 2018 · 7:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 14, 2018 | P | 2,000 | $9.0008 | A | 7,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 2,500 shares subject to restricted stock units granted on June 11, 2018. The RSUs will fully vest on the earlier of (x) June 11, 2019 (the first anniversary of the date of grant) or (y) the day prior to the 2019 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.